American Journal of Nephrology

Papers
(The TQCC of American Journal of Nephrology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Relationship Between Podocyte Injury and Renal Outcomes in Patients with Acute Kidney Injury: A Report From a Retrospective Study in China42
Clinical outcomes of patients undergoing hemodialysis with cool versus standard dialysate: A systematic review and meta-analysis.35
Serum Uric Acid Levels and Nephrosclerosis in a Population-Based Autopsy Study: The Hisayama Study33
Intrarenal Anti-Leptin Treatment Attenuates Ischemia and Reperfusion Injury28
Nephrogenic Calciphylaxis Arising after Bariatric Surgery: A Case Series28
Trends, Outcomes, and Economic Implications of Peritoneal Dialysis-Associated Peritonitis Hospitalizations: A National Cohort Study28
Body Mass Index and the Risk of Persistent Proteinuria in Middle-Aged Men: The Kansai Healthcare Study23
Characteristics and Graft Outcomes of Kidney Transplant Candidates with Enteric Risk Factors and Elevated Plasma Oxalate Levels22
Erratum20
Front & Back Matter19
Thromboelastography and Traditional Coagulation Testing in Non-ICU-Admitted Patients with Acute Kidney Injury: An Observational Cohort Study17
Association between <b><i>Opisthorchis viverrini</i></b> Infection and Glomerular Disease in Thailand17
Vagus Nerve Stimulation: A Potential Therapeutic Role in Childhood Nephrotic Syndrome?16
Renal Interstitial Inflammation Predicts Nephropathy Progression in IgA Nephropathy: A Two-Center Cohort Study16
Going Nuts to Protect Kidneys and to Live Longer with Kidney Disease15
Nurse Caseload and Patient Survival in Hemodialysis Units: A Korean Nationwide Cohort Study14
Virtual Pharmacy: An Integrated Collaborative Redesign Targeting Medication-Related Problems in Patients with Chronic Kidney Disease12
The Optimization of Outpatient Hemodialysis Management for Acute Kidney Injury Requiring Dialysis Patients: A Quality Improvement Study11
Comment on Kang et al.’s “Comparison between the Effects of Allopurinol and Febuxostat on the Survival of Patients on Maintenance Hemodialysis”11
U-Shaped Relationship between Sleep Duration and CKD in US Adults: Data from National Health and Nutrition Examination Survey (NHANES) 2005–201411
Extremely Low Dose of Erythropoiesis-Stimulating Agent May Be Associated with Increased Mortality in Hemodialysis Patients11
Role of Sodium-Glucose Cotransporter 2 Inhibitors for Management of Diabetes Mellitus in Renal Transplant Recipients and Management Strategies for Posttransplant Hypertension11
Acknowledgement to Reviewers11
Switch from Hemodialysis to Peritoneal Dialysis: Does the Time Spent on Hemodialysis Impact Outcomes in Peritoneal Dialysis?10
Exosomal Specificity of MiR-15a-5p as marker of Activity, Renal Damage and Disease Flares in Systemic Lupus Erythematosus10
Endocannabinoid System in Polycystic Kidney Disease10
Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial10
Nut Consumption and Effects on Chronic Kidney Disease and Mortality in the United States10
Association between the Estimated Glomerular Filtration Rate and Brain Atrophy in Older Adults10
Development of Urinary Diagnostic Biomarker for IgA Nephropathy by Lectin Microarray10
A 4-Variable Model to Predict Cardio-Kidney Events and Mortality in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study10
Association of Diabetes with Changes in Blood Pressure during Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial9
Urinary Sodium Excretion and Kidney Disease Progression in IgA Nephropathy: A Cohort Study9
The Clinical Impact of Urinalysis Screened by Automated Microscopy Compared to Reference Manual Analysis9
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan9
Mineralocorticoid Receptor-Associated Mechanisms in Diabetic Kidney Disease and Clinical Significance of Mineralocorticoid Receptor Antagonists8
Serum Uromodulin Levels Reflect Severity of Clinicopathological Findings in Early Stage IgA Nephropathy8
Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial8
Finerenone Reduces Renal RORγt γδ T Cells and Protects against Cardiorenal Damage8
Genetic Etiologies for Chronic Kidney Disease Revealed through Next-Generation Renal Gene Panel8
Effects of roxadustat on thyroid profiles in patients and animals with chronic kidney disease8
Telemedicine and Clinical Outcomes in Peritoneal Dialysis: A Propensity-Matched Study8
Minimal Change Disease and Focal Segmental Glomerulosclerosis are associated with good kidney prognosis and Thrombotic Microangiopathy with poor kidney survival in patients with COVID-19-associated ne7
Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients7
Clinicopathological Characteristics and Prognosis of Lupus Nephritis Patients with Acute Kidney Injury7
Safety Profile and Effectiveness of Dapagliflozin in Pediatric Patients with Chronic Kidney Disease7
Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc Analysis7
Discontinuation of Renin-Angiotensin System Inhibitors and Clinical Outcomes in Chronic Kidney Disease: A Systemic Review and Meta-Analysis7
Deliverables from Metabolomics in Kidney Disease: Adenine, New Insights, and Implication for Clinical Decision-Making7
Kidney Amyloidosis: Updates on Pathogenesis and Therapeutic Frontiers7
Plasma transcriptome profile associated with CKD progression7
Results of Salt Intake Restriction Monitored with the New Sodium Control Biosensor6
IgA Nephropathy with Crescents: A Single-Center Experience6
Erratum6
Erratum6
Association of Sevelamer Initiation with Gastrointestinal Bleeding Hospitalization in Individuals Requiring Hemodialysis6
Front & Back Matter6
Biomarkers of Covert Acid Stress in Patients with Chronic Kidney Disease: A Cross-Sectional Study6
Serum Sclerostin Levels and Mortality in Hemodialysis Patients: An 8-Year Prospective Study5
Serum Calciprotein Monomers and Chronic Kidney Disease Progression5
Urinary Fetuin-A Fragments Predict Progressive Estimated Glomerular Filtration Rate Decline in Two Independent Type 2 Diabetes Cohorts of Different Ethnicities5
Front & Back Matter5
Utility of CHA<sub>2</sub>DS<sub>2</sub>-VASc Score to Predict Mid-Term Clinical Outcomes in Hemodialysis Patients5
Autonomic Nervous System Dysfunction in Peritoneal Dialysis Patients: An Underrecognized Cardiovascular Risk Factor?5
Acute Kidney Injury in Coronavirus Disease and Association with Thrombosis5
Efficacy and Safety of Ferric Citrate on Hyperphosphatemia among Chinese Patients with Chronic Kidney Disease Undergoing Hemodialysis: A Phase III Multicenter Randomized Open-Label Active-Drug-Control5
Genetic Testing and FOX News5
Contents Vol. 53, 20225
High Renal Mast Cell Density Is Associated with Poor Prognosis in Patients with Immunoglobulin A Nephropathy5
Prevalence and Outcomes Associated with Hyperuricemia in Hospitalized Patients with COVID-194
Hemodialysis Effects on Autonomic Function: Results of Linear and Nonlinear Analysis of Heart Rate Variability at Rest and in Response to Physical and Mental Stress Tests4
Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post hoc Analysis of KALM-1 and KALM-24
Non-Alcoholic Fatty Liver Disease and Its Association with Kidney and Cardiovascular Outcomes in Moderate to Advanced Chronic Kidney Disease4
Proton Pump Inhibitors and Kidney Disease: Fact or Fiction?4
<b><i>APOL1</i></b> Risk Variants Associated with Serum Albumin in a Population-Based Cohort Study4
Expression of Concern4
The Superiority of European Kidney Function Consortium Cystatin C-Based Formula for Risk Stratification of All-Cause and Cardiovascular Deaths in US Adults4
Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism Patients4
Associations of Causes of Chronic Kidney Disease with Disease Progression and Mortality: Insights from the Fukuoka Kidney disease Registry (FKR) Study4
The role of neutrophils in venous thrombosis in primary membranous nephropathy4
Adjunctive active vitamin D (AVD) decreases kidney function during treatment of secondary hyperparathyroidism (SHPT) with extended-release calcifediol (ERC) in non-dialysis chronic kidney disease (ND-4
0.35810899734497